| Evaluation of Tumor Response to Ipilimumab in the Treatment of Melanoma With Brain Metastases (NCT00623766) | Bristol-Myers Squibb | 2008-07-01 |
| BMS-741672 for Diabetic Neuropathic Pain (NCT00683423) | Bristol-Myers Squibb | 2008-07-01 |
| Single Dose Study of BMS-820836 (NCT00964912) | Bristol-Myers Squibb | 2008-07-01 |
| A Long-Term Study of the Effects of Orally Administered SAR302503 in Patients With Myelofibrosis (NCT00724334) | Bristol-Myers Squibb | 2008-07-01 |
| A Phase 1 Study of BMS-833923 (XL139) in Subjects With Advanced or Metastatic Cancer (NCT00670189) | Bristol-Myers Squibb | 2008-07-01 |
| A Phase I Study of BMS-641988 in Japanese Patients With Castration Resistant Prostate Cancer (NCT00644488) | Bristol-Myers Squibb | 2008-07-01 |
| Efficacy and Safety Study of Apixaban for the Treatment of Deep Vein Thrombosis or Pulmonary Embolism (NCT00643201) | Bristol-Myers Squibb | 2008-07-01 |
| Suboptimal Responders to Adefovir Switching to Entecavir (NCT00718887) | Bristol-Myers Squibb | 2008-07-01 |
| Efficacy Study of Ipilimumab Versus Placebo to Prevent Recurrence After Complete Resection of High Risk Stage III Melanoma (NCT00636168) | Bristol-Myers Squibb | 2008-06-30 |
| Phase II Study of Brivanib (BMS-582664) to Treat Multiple Tumor Types (NCT00633789) | Bristol-Myers Squibb | 2008-06-01 |
| Phase IIIB Switching From Intravenous to Subcutaneous Study (NCT00663702) | Bristol-Myers Squibb | 2008-05-01 |
| A Multiple Ascending Dose Study of Daclatasvir (BMS-790052) in Hepatitis C Virus Genotype 1 Infected Subjects (NCT00663208) | Bristol-Myers Squibb | 2008-05-01 |
| Efficacy and Safety Study of Apixaban for Extended Treatment of Deep Vein Thrombosis or Pulmonary Embolism (NCT00633893) | Bristol-Myers Squibb | 2008-05-01 |
| Phase I/II Combination With Irinotecan- Erbitux (NCT00594984) | Bristol-Myers Squibb | 2008-05-01 |
| A Single Ascending Dose Study of BMS-791325 in HCV Infected Subjects (NCT00664625) | Bristol-Myers Squibb | 2008-05-01 |
| Dasatinib in Combination With Revlimid (and Dexamethasone) (NCT00560391) | Bristol-Myers Squibb | 2008-05-01 |
| A Study of MDX-1100 in Subjects With Active Ulcerative Colitis (NCT00656890) | Bristol-Myers Squibb | 2008-04-01 |
| Study to Evaluate KOS-1584 in Patients With Advanced or Metastatic Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) (NCT00651508) | Bristol-Myers Squibb | 2008-04-01 |
| The Effect of Omeprazole on the Pharmacokinetics of Dasatinib in Healthy Subjects (NCT00655746) | Bristol-Myers Squibb | 2008-04-01 |
| Study of MDX-1411 Given Every 14 Days With Pre-medications to Subjects With Clear Cell Kidney Cancer. (NCT00656734) | Bristol-Myers Squibb | 2008-04-01 |
| Multiple Dose Study In Cancer Patients: Safety and Tolerability of BMS-754807 in Advanced or Metastatic Solid Tumors (NCT00569036) | Bristol-Myers Squibb | 2008-04-01 |
| Drug Interaction Study (NCT00646776) | Bristol-Myers Squibb | 2008-04-01 |
| Clinical Trial of Intravenous Alvespimycin in Patients With Her2 Positive Breast Cancer (NCT00780000) | Bristol-Myers Squibb | 2008-04-01 |
| A Study to Assess the Pharmacodynamics (PD) of Prednisoline in Healthy Male Subject (NCT03196557) | Bristol-Myers Squibb | 2008-03-31 |
| Long Term Experience With Abatacept in Routine Clinical Practice (NCT02109666) | Bristol-Myers Squibb | 2008-03-01 |
| Multiple Ascending Dose Study of BMS-777607 in Subjects With Advanced or Metastatic Solid Tumors (NCT00605618) | Bristol-Myers Squibb | 2008-03-01 |
| Entecavir Plus Adefovir Combination Therapy Versus Entecavir Monotherapy vs Therapy With Adefovir Plus Lamivudine for Chronic Hepatitis B Infected Subjects With Lamivudine-resistant Virus (NCT00410202) | Bristol-Myers Squibb | 2008-03-01 |
| Belatacept Pharmacokinetic Trial in Renal Transplantation (NCT00578448) | Bristol-Myers Squibb | 2008-03-01 |
| Rollover Study of Weekly Paclitaxel (BMS-181339) in Patients With Advanced or Recurrent Esophageal Cancer (NCT00971841) | Bristol-Myers Squibb | 2008-03-01 |
| PoC in Rheumatoid Arthritis With Methotrexate (NCT00605735) | Bristol-Myers Squibb | 2008-03-01 |
| Phase II, 2nd Line Melanoma - RAND Monotherapy (NCT00612664) | Bristol-Myers Squibb | 2008-03-01 |
| Study of MDX-1100 (Anti-CXCL10 Human Monoclonal Antibody) in Combination With Methotrexate in Subjects With Active Rheumatoid Arthritis (RA) (NCT01017367) | Bristol-Myers Squibb | 2008-02-01 |
| Phase 1 Study of MDX-1401 in Patients With CD30-positive Refractory/Relapsed Hodgkin's Lymphoma (NCT00634452) | Bristol-Myers Squibb | 2008-02-01 |
| A Study of Tanespimycin (KOS-953) in Patients With Multiple Myeloma in First Relapse (NCT00546780) | Bristol-Myers Squibb | 2008-02-01 |
| Phase II Study for Previously Untreated Subjects With Non Small Cell Lung Cancer (NSCLC) or Small Cell Lung Cancer (SCLC) (NCT00527735) | Bristol-Myers Squibb | 2008-02-01 |
| Study of the Safety of MDX-1342 in Combination With Methotrexate in Patients With Rheumatoid Arthritis (NCT00639834) | Bristol-Myers Squibb | 2008-02-01 |
| Safety Study of Dasatinib With Bortezomib (Velcade®) and Dexamethasone for Multiple Myeloma (NCT00560352) | Bristol-Myers Squibb | 2008-02-01 |
| A Phase 1/2 Study of Epofolate (BMS-753493) in Subjects With Advanced Cancer (Schedule 1) (NCT00546247) | Bristol-Myers Squibb | 2008-01-01 |
| A Study of BMS-663513 in Combination With Chemoradiation in Subjects With Non Small Cell Lung Carcinoma (NSCLC) (NCT00461110) | Bristol-Myers Squibb | 2008-01-01 |
| Pharmacokinetics and Metabolism of Radiolabeled BMS-690514 in Healthy Male Subjects (NCT00578916) | Bristol-Myers Squibb | 2008-01-01 |
| Methotrexate-Inadequate Response Study (NCT00559585) | Bristol-Myers Squibb | 2008-01-01 |
| A Single Ascending Dose Study of BMS-650032 in HCV Infected Subjects (NCT00559247) | Bristol-Myers Squibb | 2008-01-01 |
| Belatacept in Liver Transplant Recipients (NCT00555321) | Bristol-Myers Squibb | 2008-01-01 |
| Phase IIIB Subcutaneous Abatacept Monotherapy Study (NCT00547521) | Bristol-Myers Squibb | 2007-12-01 |
| Subcutaneous Pharmacokinetics of Belatacept (NCT00569803) | Bristol-Myers Squibb | 2007-12-01 |
| A Phase 1/2 Study of Epofolate (BMS-753493) in Subjects With Advanced Cancer (Schedule 2) (NCT00550017) | Bristol-Myers Squibb | 2007-12-01 |
| Dasatinib in Imatinib Resistant/Intolerant Chinese CML (Chronic and Advanced Phase) Subjects (NCT00529763) | Bristol-Myers Squibb | 2007-11-17 |
| Safety and Efficacy of Abatacept Versus Placebo in Participants With Psoriatic Arthritis (NCT00534313) | Bristol-Myers Squibb | 2007-11-01 |
| Phase I Study of BMS-690514 in Japanese Patients With Solid Tumors (NCT00516451) | Bristol-Myers Squibb | 2007-11-01 |
| A Phase 4 Study to Assess the Effects of Aripiprazole Versus Other Atypical Antipsychotics in the Treatment of Schizophrenic Patients With Metabolic Syndrome (NCT00508157) | Bristol-Myers Squibb | 2007-11-01 |
| A Single Ascending Dose Study of Daclatasvir (BMS-790052) in Hepatitis C Virus Infected Subjects (NCT00546715) | Bristol-Myers Squibb | 2007-11-01 |
| Phase IIIB Subcutaneous Missed Dose Study (NCT00533897) | Bristol-Myers Squibb | 2007-11-01 |
| Long-term Safety of Dasatinib in Patients With Chronic Myelogenous Leukemia or Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (NCT00982488) | Bristol-Myers Squibb | 2007-10-01 |
| A Study to Evaluate the Discontinuation Effect of Clopidogrel After Drug Eluting Stent Implantation in Non-diabetic Patients (NCT00493779) | Bristol-Myers Squibb | 2007-10-01 |
| Study to Assess Effectiveness of Giving Combination of Standard Chemotherapy Drugs Versus Combination of Standard Chemotherapy and New Drug Ixabepilone When Given Before Surgical Removal of Early Stage Breast Cancer (NCT00455533) | Bristol-Myers Squibb | 2007-10-01 |
| A Study of BMS-582664 in Patients With Advanced or Metastatic Solid Tumors (NCT00390936) | Bristol-Myers Squibb | 2007-10-01 |
| A Phase I Study of BMS-690514 in Combination With Paclitaxel and Carboplatin (NCT00420186) | Bristol-Myers Squibb | 2007-10-01 |
| A Phase III Study of Dasatinib vs Imatinib in Patients With Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia (NCT00481247) | Bristol-Myers Squibb | 2007-09-01 |
| Combination Trial of BMS-690514 in Combination With FOLFIRI and FOLFOX (NCT00479583) | Bristol-Myers Squibb | 2007-09-01 |
| A Phase I Study to Determine Absorption, Distribution, Metabolism, and Elimination of a Single Radiolabeled Dose of Brivanib (BMS-582664) (NCT00435669) | Bristol-Myers Squibb | 2007-09-01 |
| A Study of BMS-663513 Administered in Combination With Chemotherapy to Subjects With Advanced Solid Malignancies (NCT00351325) | Bristol-Myers Squibb | 2007-09-01 |
| A Study of the Interaction of Rifampin and Vinflunine in Subjects With Advanced Cancer (NCT00534807) | Bristol-Myers Squibb | 2007-09-01 |
| A Phase III Study of Apixaban in Patients With Atrial Fibrillation (NCT00496769) | Bristol-Myers Squibb | 2007-08-31 |
| Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of BMS-686117 in Subjects With Type 2 Diabetes (NCT00508287) | Bristol-Myers Squibb | 2007-08-01 |
| DDI HV (ATV - Merck) (NCT00518297) | Bristol-Myers Squibb | 2007-08-01 |
| A Study of BMS-582949 in Patients With Moderate to Severe Plaque Psoriasis (NCT00399906) | Bristol-Myers Squibb | 2007-08-01 |
| A Study of Tanespimycin (KOS-953) in Patients With Relapsed-refractory Multiple Myeloma (NCT00514371) | Bristol-Myers Squibb | 2007-08-01 |
| A Phase II Study of Belatacept (BMS-224818) With a Steroid-free Regimen in Subjects Undergoing Kidney Transplantation (NCT00455013) | Bristol-Myers Squibb | 2007-07-01 |
| A Study of Brivanib (BMS-582664) in Patients With Liver Cancer and Mild, Moderate or Severe Liver Dysfunction (NCT00437424) | Bristol-Myers Squibb | 2007-07-01 |
| Study of Dasatinib and Docetaxel in Metastatic Hormone Refractory Prostate Cancer (NCT00439270) | Bristol-Myers Squibb | 2007-07-01 |
| Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder (NCT00481325) | Bristol-Myers Squibb | 2007-07-01 |
| A Study of Entecavir in Pediatric Patients With Chronic Hepatitis B Virus (HBV)-Infection (NCT00423891) | Bristol-Myers Squibb | 2007-06-30 |
| Efficacy and Safety Study of Abatacept to Treat Lupus Nephritis (NCT00430677) | Bristol-Myers Squibb | 2007-06-01 |
| Study of an Investigational Drug for the Prevention of Thrombosis-related Events Following Knee Replacement Surgery (NCT00452530) | Bristol-Myers Squibb | 2007-06-01 |
| Phase 1 Drug Interaction Study of Apixaban and Atenolol in Healthy Subjects (NCT02262533) | Bristol-Myers Squibb | 2007-06-01 |
| Study to Evaluate the Safety, Pharmacokinetics and Tolerability of BMS-708163 (NCT01454115) | Bristol-Myers Squibb | 2007-06-01 |
| A Multiple-Dose Study of Sinemet® CR (Carbidopa/Levodopa) in Healthy Subjects (NCT00460954) | Bristol-Myers Squibb | 2007-06-01 |
| Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness (NCT00457002) | Bristol-Myers Squibb | 2007-06-01 |
| Long-term Data Collection for Subjects in MDX-010 Studies (NCT00928031) | Bristol-Myers Squibb | 2007-06-01 |
| Phase I Study of Dasatinib (BMS-354825) and Capecitabine for Women With Advanced Breast Cancer (NCT00452673) | Bristol-Myers Squibb | 2007-06-01 |
| A Phase IIIb Study of BMS-188667 in Subjects With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate (NCT00420199) | Bristol-Myers Squibb | 2007-05-01 |
| A Study of Dasatinib in Chronic Phase Philadelphia Chromosome Positive Chronic Myeloid Leukemia (NCT00482703) | Bristol-Myers Squibb | 2007-05-01 |
| Substudy - Low Dose of Abatacept in Subjects With Rheumatoid Arthritis (NCT00989235) | Bristol-Myers Squibb | 2007-04-01 |
| Entecavir Plus Tenofovir Combination Therapy Versus Entecavir Monotherapy in Naive Subjects With Chronic Hepatitis B (NCT00410072) | Bristol-Myers Squibb | 2007-04-01 |
| A Study of Dasatinib vs. High-Dose Imatinib (600 mg) in Patients With Chronic Phase Chronic Myeloid Leukemia (CML) Who Failed to Achieve Complete Cytogenetic Response After 3-18 Months of Imatinib Therapy (NCT00362466) | Bristol-Myers Squibb | 2007-04-01 |
| Antiviral Activity of Entecavir in Patients Receiving Liver Transplant Due to Chronic Hepatitis B Virus Infection (NCT00395018) | Bristol-Myers Squibb | 2007-04-01 |
| A Phase III Study of Abatacept in Patients With Rheumatoid Arthritis and an Inadequate Response to Methotrexate (NCT00409838) | Bristol-Myers Squibb | 2007-04-01 |
| Study of Neoadjuvant Ipilimumab in Patients With Urothelial Carcinoma Undergoing Surgical Resection (NCT00362713) | Bristol-Myers Squibb | 2007-03-01 |
| Study of an Investigational Drug for the Prevention of Thrombosis-related Events Following Hip Replacement Surgery (ADVANCE-3) (NCT00423319) | Bristol-Myers Squibb | 2007-03-01 |
| A Study of Vinflunine in Patients With Gastric Cancer (NCT00359476) | Bristol-Myers Squibb | 2007-03-01 |
| A Study in Korea of Entecavir Versus Lamivudine in Adults With Chronic Hepatitis B Infection (NCT00393484) | Bristol-Myers Squibb | 2007-02-01 |
| Safety, Tolerability and Pharmacokinetics of Efavirenz in HIV-Infected Children (NCT00364793) | Bristol-Myers Squibb | 2007-02-01 |
| A Multiple Ascending Dose Study of BMS-707035 in HIV-1 Infected Subjects (NCT00397566) | Bristol-Myers Squibb | 2007-02-01 |
| Study of Dasatinib (BMS-354825) in Patients With Solid Tumors (NCT00339144) | Bristol-Myers Squibb | 2007-01-01 |
| First-Line Treatment of Advanced Bladder Cancer Randomized vs. Gemcitabine ± Vinflunine in Patients Ineligible to Receive Cisplatin-Based Therapy (NCT00389155) | Bristol-Myers Squibb | 2007-01-01 |
| A Study of BMS-224818 (Belatacept) in Patients Who Have Undergone a Kidney Transplant and Are Currently on Stable Cyclosporine or Tacrolimus Regimen With or Without Corticosteroids (NCT00402168) | Bristol-Myers Squibb | 2007-01-01 |
| Phase II Study of Dasatinib (BMS-354825) for Androgen-deprived Progressive Prostate Cancer (NCT00385580) | Bristol-Myers Squibb | 2007-01-01 |
| Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation (NCT00412984) | Bristol-Myers Squibb | 2006-12-31 |
| A Phase II Open Label Study of BMS-582664 in Locally Advanced or Metastatic Hepatocellular Cancer (NCT00355238) | Bristol-Myers Squibb | 2006-12-31 |
| Study of Entecavir in Patients With Chronic Hepatitis B Virus (HBV) Infection (NCT00388674) | Bristol-Myers Squibb | 2006-12-18 |